
BIOPHEN™ DiXaI — To-trinns Anti-Xa for direkte Xa-hemmere
Pris: 440,00 dollar
ProduktbeskrivelseKun til forskningsbruk. Ikke til bruk i diagnostiske prosedyrer. Two-stage chromogenic anti-Xa method specifically designed for the quantitative measurement of direct Factor Xa inhibitors (DiXaIs) in citrated human plasma: Rivaroxaban (Xarelto®), Apixaban (Eliquis®), and Edoxaban (Lixiana®). Important: This method is NOT suitable for indirect inhibitors such as heparins or Fondaparinux. Use BIOPHEN™ Heparin LRT (ref. 221011/221013/221015) for those analytes.
Produktegenskaper
Produktkomponenter
|
Produktapplikasjoner
For the measurement of Rivaroxaban, Apixaban, and other direct Factor Xa inhibitors in research applications.
BruksanvisningDatablad/Tekniske dataAnalysebevis (COA) |